METHAMPHETAMINE-DEPENDENCE

Clinical trials for METHAMPHETAMINE-DEPENDENCE explained in plain language.

Never miss a new study

Get alerted when new METHAMPHETAMINE-DEPENDENCE trials appear

Sign up with your email to follow new studies for METHAMPHETAMINE-DEPENDENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 2 Completed 3

Could a weight-loss drug curb meth addiction? new trial aims to find out.

Disease control Not yet recruiting

This study tests whether semaglutide (Wegovy), a drug used for diabetes and weight loss, can help people reduce or stop using methamphetamine. It involves 162 adults with moderate to severe methamphetamine use disorder who will receive either the drug or a placebo over 12 weeks. …

Matched conditions: METHAMPHETAMINE-DEPENDENCE

Phase: PHASE2 • Sponsor: San Francisco Department of Public Health • Aim: Disease control

Last updated May 17, 2026 05:42 UTC

METHAMPHETAMINE-DEPENDENCE

Get alerted when new METHAMPHETAMINE-DEPENDENCE trials appear

Could a weight-loss drug curb meth addiction? new trial aims to find out.